19:00 às 19:30 - BLOCO 3 - HIGHLIGHTS ESTADIO III e IV (imunoterapia)

19:10 às 19:15 - OA09.01 - First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA